Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2018, Article ID 8143582, 26 pages
https://doi.org/10.1155/2018/8143582
Research Article

An Assessment of the Genotoxicity and Subchronic Toxicity of a Supercritical Fluid Extract of the Aerial Parts of Hemp

1AIBMR Life Sciences, Inc., 2800 E Madison St., Suite 202, Seattle, WA 98112, USA
2Toxi-Coop Zrt., Magyar Jakobinusok Tere 4/B, Budapest 1122, Hungary

Correspondence should be addressed to John R. Endres; moc.rmbia@nhoj

Received 6 December 2017; Revised 6 March 2018; Accepted 7 May 2018; Published 7 June 2018

Academic Editor: Lucio Guido Costa

Copyright © 2018 Tennille K. Marx et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Atakan, “Cannabis, a complex plant: Different compounds and different effects on individuals,” Therapeutic Advances in Psychopharmacology, vol. 2, no. 6, pp. 241–254, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. G. Pertwee, “Cannabinoid pharmacology: the first 66 years,” British Journal of Pharmacology, vol. 147, supplement 1, pp. S163–S171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. J. Robson, “Therapeutic potential of cannabinoid medicines,” Drug Testing and Analysis, vol. 6, no. 1-2, pp. 24–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. ElSohly and D. Slade, “Chemical constituents of marijuana: the complex mixture of natural cannabinoids,” Life Sciences, vol. 78, no. 5, pp. 539–548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Mehmedic, S. Chandra, D. Slade et al., “Potency Trends of Δ9-THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008*,” Journal of Forensic Sciences, vol. 55, no. 5, pp. 1209–1217, 2010. View at Publisher · View at Google Scholar
  6. E. W. Bow and J. M. Rimoldi, “The structure-function relationships of classical cannabinoids: CB1/CB2 modulation,” Perspectives in Medicinal Chemistry, vol. 8, pp. 17–39, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. E. B. Russo, “Cannabidiol Claims and Misconceptions,” Trends in Pharmacological Sciences, vol. 38, no. 3, pp. 198–201, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Cacciola, R. Chianese, T. Chioccarelli et al., “Cannabinoids and reproduction: A lasting and intriguing history,” Pharmaceuticals, vol. 3, no. 10, pp. 3275–3323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Meccariello and R. Chianese, Cannabinoids in Health and Disease, InTech, 2016. View at Publisher · View at Google Scholar
  10. G. Turu and L. Hunyady, “Signal transduction of the CB1 cannabinoid receptor,” Molecular Endocrinology, vol. 44, no. 2, pp. 75–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Pacher and R. Mechoulam, “Is lipid signaling through cannabinoid 2 receptors part of a protective system?” Progress in Lipid Research, vol. 50, no. 2, pp. 193–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Battista, R. Meccariello, G. Cobellis et al., “The role of endocannabinoids in gonadal function and fertility along the evolutionary axis,” Molecular and Cellular Endocrinology, vol. 355, no. 1, pp. 1–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Bergamaschi, R. H. C. Queiroz, A. W. Zuardi, and J. A. S. Crippa, “Safety and side effects of cannabidiol, a Cannabis sativa constituent,” Current Drug Safety, vol. 6, no. 4, pp. 237–249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Iffland and F. Grotenhermen, “An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies,” Cannabis and Cannabinoid Research, vol. 2, no. 1, pp. 139–154, 2017. View at Publisher · View at Google Scholar
  15. H. Rosenkrantz, R. W. Fleischman, and R. J. Grant, “Toxicity of short-term administration of cannabinoids to rhesus monkeys,” Toxicology and Applied Pharmacology, vol. 58, no. 1, pp. 118–131, 1981. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Clewell, “A comprehensive toxicological safety assessment of an extract of Olea europaea L. leaves (Bonolive«). The Toxicologist, Supplement to Toxicological Sciences,” in A comprehensive toxicological safety assessment of an extract of Olea europaea L. leaves (Bonolive®). The Toxicologist, vol. 150, p. 1457, p. Abstract #1457, 150(1, 2016. View at Google Scholar
  17. B. N. Ames, J. McCann, and E. Yamasaki, “Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test,” Mutation Research/Environmental Mutagenesis and Related Subjects, vol. 31, no. 6, pp. 347–363, 1975. View at Publisher · View at Google Scholar
  18. D. M. Maron and B. N. Ames, “Revised methods for the Salmonella mutagenicity test,” Mutation Research, vol. 113, no. 3-4, pp. 173–215, 1983. View at Publisher · View at Google Scholar · View at Scopus
  19. “The Salmonella typhimurium/mammalian microsomal assay, a report of the U.S. environmental protection agency Gene-Tox program,” Mutation Research/Reviews in Genetic Toxicology, vol. 168, no. 3, p. 356, 1986. View at Publisher · View at Google Scholar
  20. S. Venitt and J. Parry, Mutagenicity testing, a practical approach, IRL Press Limited, Eynsham , Oxford England, 1984.
  21. OECD, “Bacterial Reverse Mutation Test, OECD Guidelines for the Testing of Chemicals,” OECD Guidelines for the Testing of Chemicals Test No. 471, OECD Publishing, Paris, France, 1997, Section 4. View at Google Scholar
  22. European Commission, “Council Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH),” Official Journal of the European Union: Brussels, pp. L 142/–1-L142/739.
  23. “ICH Harmonised Tripartite Guideline: Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use,” in Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, pp. 1–25, 2011.
  24. OECD, “In Vitro Mammalian Chromosomal Aberration Test,” OECD Guidelines for the Testing of Chemicals Test No. 473, 2014, Section 4, p. 20. View at Publisher · View at Google Scholar
  25. EPA, “Health Effects Test Guidelines,” OPPTS 870.5375 In vitro mammalian chromosome aberration test, 1998, p. 1-11. View at Google Scholar
  26. D. Hamden et al., “ISCN 1985: an international system for human cytogenic nomenclature,” Report of the Standing Committee on Human Cytogenic Nomenclature, p. 1-117.
  27. J. R. Savage, “Classification and relationships of induced chromosomal structual changes.,” Journal of Medical Genetics, vol. 13, no. 2, pp. 103–122, 1976. View at Publisher · View at Google Scholar
  28. NRC, “Guide for the care and use of laboratory animals,” in Committee for the Update of the Guide for the Care and Use of Laboratory Animals, pp. 1–220, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council, Washington DC., USA, 8th edition, 2011. View at Publisher · View at Google Scholar
  29. OECD, “Mammalian Erythrocyte Micronucleus Test,” OECD Guidelines for the Testing of Chemicals Test No. 474, OECD Publishing, Paris, France, 2014, Section 4, p. 21. View at Google Scholar
  30. EPA, Health Effects Test Guidelines. OPPTS 870.5395. Mammalian erythrocyte micronucleus test, 1998, p. 1-10.
  31. OECD, “Repeated Dose 28-day Oral Toxicity Study in Rodents,” OECD Guidelines for the Testing of Chemicals Test, No. 407, OECD Publishing, Paris, France, 2008, Section 4. View at Google Scholar
  32. FDA, “Redbook 2000,” Toxicological principles for the safety assessment of food ingredients IV.C.3.a, 2003, Short-term toxicity studies with rodents. View at Google Scholar
  33. OECD, “Repeated Dose 90-Day Oral Toxicity Study in Rodents,” OECD Guidelines for the Testing of Chemicals Test No. 408, OECD Publishing, Paris, France, 1998, Section 4. View at Google Scholar
  34. FDA, “Redbook 2000,” Toxicological principles for the safety assessment of food ingredient IV.C.4.a, 2003, Subchronic toxicity studies with rodents. View at Google Scholar
  35. M. H. Hanigan and H. C. Pitot, “Gamma-glutamyl transpeptidase - its role in hepatocarcinogenesis,” Carcinogenesis, vol. 6, no. 2, pp. 165–172, 1985. View at Publisher · View at Google Scholar · View at Scopus
  36. T. B. Leonard, D. A. Neptun, and J. A. Popp, “Serum gamma glutamyl transferase as a specific indicator of bile duct lesions in the rat liver,” The American Journal of Pathology, vol. 116, no. 2, pp. 262–269, 1984. View at Google Scholar · View at Scopus
  37. M. Hamlin and D. Banas, “Adrenal gland,” in Pathology of the Fischer rat, Reference and Atlas, pp. 501–518, Academic Press, San Diego, 1990. View at Google Scholar
  38. NTP and DHHS, “Nonneoplastic Lesion Atlas,” A guide for standardizing terminology in toxicologic pathology for rodents.
  39. G. Boorman and S. Eustis, “Lung in,” in Pathology of the Fischer rat: reference and atlas, G. Boorman et al., Ed., pp. 339–367, Academic Press, San Diego, 1990. View at Google Scholar
  40. J. Vidal et al., “Reproductive system and mammary gland,” in Toxicologic pathology. Nonclinical safety assessment, vol. Chapter 18, pp. 717–830, CRC Press, Boca Raton, 2013. View at Google Scholar
  41. NTP and DHHS, Nonneoplastic Lesion Atlas. Kidney - cyst, 2014, https://ntp.niehs.nih.gov/nnl/urinary/kidney/cyst/index.htm.
  42. S. C. Gad, Ed., Animal models in toxicology. Second edition, CRC Press, Boca Raton, 2nd edition, 2007.
  43. T. Marx et al., “An Assessment of the Genotoxicity and Subchronic Toxicity of a Supercritical Fluid Extract of the Aerial Parts of Hemp,” in Proceedings of the Poster session presented at SOT Annual Meeting and ToxExpo, 2018.